Vitamin D;Vitamina D: Actualización

Revista Medica de Rosario

Volumn 76, Issue 2, 2010, Pages 70-87

  Sánchez, Ariel ^a,b  

^a Expresidente de la Asociación Argentina de Osteología y Metabolismo Mineral   (Argentina)

^b NONE   (Argentina)

Author keywords

Bone health; Cholecalciferol; Deficiency; Ergocalciferol; Supplementation; Vitamin D

Indexed keywords

COLECALCIFEROL; ERGOCALCIFEROL; VITAMIN D;

BRAIN DEVELOPMENT; CARDIOVASCULAR SYSTEM; CELL GROWTH; IMMUNE SYSTEM; IMMUNOMODULATION; OSTEOPOROSIS; REVIEW; SECONDARY HYPERPARATHYROIDISM; VITAMIN D METABOLISM; VITAMIN DEFICIENCY;

EID: 78149486709     PISSN: 03275019     EISSN: 18512135     Source Type: Journal    
DOI: None     Document Type: Review

References (134)

1. Sánchez A, Puche R, Zeni S, y col. Papel del calcio y la vitamina D en la salud ósea. Rev Esp Enf Metab Óseas 11: 201-17, 2002 (Parte I);
2. 12: 14-29, 2003 (Parte II).
3. Binkley N, Krueger D, Lensmeyer G. 25-hydroxyvitamin D measurement, 2009: A review for clinicians. J Clin Densitom 12: 417-27, 2009.
4. Pike JW, Meyer MC, Martowicz ML. New techniques in transcription research extend our understanding of the molecular actions of the vitamin D hormone. IBMS BoneKEy 6: 169-80, 2009.
5. Suda T, Shinki T, Takahashi N. The role of vitamin D in bone and intestinal cell differentiation. Annu Rev Nutr 10: 195-211, 1990. (Pubitemid 20223390)
6. Norman AW. Intestinal calcium absorption: a vitamin D-hormone-mediated adaptative response. Am J Clin Nutr 51: 190-300, 1990.
7. 3-dependent transcaltachia (the rapid stimulation of duodenal Ca2+ transport). Endocrinology 127: 2475-80, 1990.
8. 3-mediated intestinal calcium absorption. Miner Electrolyte Metab 16: 109-14, 1990.
9. 3 analog structure-function assessment of the rapìd stimulation of intestinal calcium absorption (transcaltachia). J Bone Miner Res 7: 457-63, 1992.
10. Dambacher MA, Schacht E. Osteoporosis y los metabolitos activos de la vitamina D. Litera Rheumatologica 18. EULAR; Zurich, 1997.
11. Findlay D, Kogawa M, Anderson P, Morris H, Atkins G. The metabolism of 25(OH)-vitamin D3 by osteoclasts and their precursors regulates the differentiation and function of osteoclasts. Comunicación a la Reunión Anual de la American Society for Bone and Mineral Research; Denver, 2009.
12. Masuyama R, Stockmans I, Torrekens S, y col. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 116: 3150-9, 2006.
13. Anderson P, Lam N, Sawyer R, y col. Bone loss due to vitamin D-deficiency is a result of reduced osteoblastic vitamin D activity. Comunicación a la Reunión Anual de la American Society for Bone and Mineral Research; Denver, 2009.
14. Anderson PH, Sawyer RK, Moore AJ, May BK, O'Loughlin PD, Morris HA. Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model. J Bone Miner Res 23: 1789-97, 2008.
15. Bordier P, Rasmussen H, Marie P, Miravet L, Gueris J, Ryckwaert A. Vitamin D metabolites and bone mineralization in man. J Clin Endocrinol Metab 46: 284-94, 1978. (Pubitemid 8312330)
16. AmLing M, Priemel M, Holzmann T, y col. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 140: 4982-7, 1999.
17. Marks HD, Fleet JC, Peleg S. Transgenic expression of the human Vitamin D receptor (hVDR) in the duodenum of VDR-null mice attenuates the age-dependent decline in calcium absorption. J Steroid Biochem Mol Biol 103: 513-6, 2007.
18. Fu L, Tang T, Miao Y, Hao Y, Dai K. Effect of 1,25- dihydroxy vitamin D3 on fracture healing and bone remodeling in ovariectomized rat femora. Bone 44: 893-8, 2009.
19. Kovacs C, Kronenberg HM. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium and lactation. Endocrine Rev 18: 832-72, 1997. (Pubitemid 28009569)
20. Sowers M. Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosis. J Bone Miner Res 11: 1052-9, 1996.
21. Oliveri M, Mautalen C, Alonso A, y col. Estado nutricional de vitamina D en madres y neonatos de Ushuaia y Buenos Aires. Medicina (B Aires) 53: 315-20, 1993.
22. Hollis BW. Vitamin D requirement during pregnancy and lactation. J Bone Miner Res 22(Suppl 2): V39-44, 2007.
23. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab 92: 3517-22, 2007.
24. Catov JM, Nohr EA, Bodnar LM, Knudson VK, Olsen SF, Olsen J. Association of periconceptional multivitamin use with reduced risk of preeclampsia among normal-weight women in the Danish National Birth Cohort. Am J Epidemiol 169: 1304-11, 2009.
25. Prentice A. Calcium in pregnancy and lactation. Annu Rev Nutr 20: 249-72, 2000.
26. Prentice A, Yan L, Jarjou L, y col. Vitamin D status does not influence the breast-milk calcium concentration of lactating mothers accustomed to a low calcium intake. Acta Pediatr 86: 1006-8, 1997. (Pubitemid 27425601)
27. Javaid MK y col. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet 367: 36-43, 2006. (Pubitemid 43038668)
28. Nwosu BU y col. Multifetal pregnancy may increase the risk for severe maternal and neonatal vitamin D deficiency. Case report. Endocrinologist 18: 172-5, 2008.
29. Cranney A y col. Effectiveness and safety of vitamin D in relation to bone health. Evidence Report/Technology Assessment No. 158 (Prepared by the University of Ottawa Evidence-based Practice Center (UO-EPC) under Contract No. 290-02-0021. AHRQ Publication No. 07-E013. Rockville, MD: Agency for Healthcare Research and Quality, August 2007.
30. Kovacs C. Calcium and bone metabolism in pregnancy and lactation. J Clin Endocrinol Metab 86: 2344-8, 2001. (Pubitemid 32545674)
31. Dawson-Hughes B, Harris SS, Finneran S. Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 80: 3657-61, 1995.
32. Wolf R, Cauley J, Baker C, y col. Factors associated with calcium absorption efficiency in pre. and perimenopausal women. Am J Clin Nutr 72: 466-71, 2000.
33. Riggs BL, Melton JL. Evidence of two distinct syndromes of involutive osteoporosis. Am J Med 75: 899-90, 1983.
34. Nordin BE, Need AG, Morris HA, Horowitz M, Robertson WG. Evidence for a renal calcium leak in postmenopausal women. J Clin Endocrinol Metab 72: 401-7, 1991.
35. Francis RM, Peacock M, Taylor GA, Storer JH, Nordin BE. Calcium malabsorption in elderly women with vertebral fractures: evidence for resistance to the action of vitamin D metabolites on the bowel. Clin Sci (Lond) 66: 103-7, 1984.
36. Bouillon R, Carmeliet G, Boonen S. Ageing and calcium metabolism. Bailliéres' Clinical Endocrinol Metab 11: 341-65, 1997.
37. Recker RR. Calcium absorption and achlorhydria. N Engl J Med 313: 70-3, 1985.
38. Russell RM. Changes in gastrointestinal function attributed to aging. Am J Clin Nutr 55: 1203-7S, 1992.
39. Halloran B, Portale A. Vitamin D metabolism: the effect of aging. En: Vitamin D (Feldman D, Glorieux F, Pike JW, eds). Academic Press; San Diego, 1997. Pp 541-56.
40. Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D and solar ultraviolet radiation. Lancet 4: 1104-5, 1989. (Pubitemid 19264108)
41. Holick M. Vitamin D: Photobiology, metabolism, mechanism of action, and clinical applications. En: Primer on the metabolic bone diseases and disorders of mineral metabolism, 4th edition. (Favus M, ed.). Philadelphia: Lippincott Williams & Wilkins; 1999. Pp 92-8.
42. Harris SS, Dawson-Hughes B, Perrone GA. Plasma 25-hydroxyvitamin D responses of younger and older men to three weeks of supplementation with 1800 IU/day of vitamin D. J Am Coll Nutr 18: 470-4, 1999.
43. Kinyamu HK, Gallagher C, Petranik KM, Ryschon KL. Effect of parathyroid hormone (hPTH1-34) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal women. J Bone Miner Res 11: 1400-5, 1996.
44. Freaney R, Mac Brinn, MacKenna M. Secondary hyperparathyroidism in elderly people: combined effect of renal insufficiency and vitamin D deficiency. Am J Clin Nutr 54: 187-91, 1993.
45. Parfitt MA, Gallagher JC, Heaney RP, y col. Vitamin D and bone health in the elderly. Am J Clin Nutr 36: 1014-31, 1982.
46. Chapuy MC, Meunier P. Vitamin D insufficiency in adults and elderly. En: Vitamin D (Feldman D, Glorieux F, Pike JW, eds.). New York: Academic Press; 1997. Pp 679-93.
47. Dawson-Hughes B, Harris S, Dallal GE. Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr 65: 67-71, 1997.
48. 3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327: 1637-42, 1992.
49. Gómez Alonso C, Naves Díaz M, Fernández Martín JL, y col. Vitamin D levels and prevalence of secondary hyperparathyroidism in a Spanish population-based sample aged 54 to 89 (Abstract). J Bone Miner Res 16(Suppl 1): S156, 2001.
50. MacKenna M, Freaney R. Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D. Osteoporos Int 8(Suppl): S3-S6, 1998.
51. Chapuy MC, Shott AM, Garnero P, y col. Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. J Clin Endocrinol Metab 81: 1129-33, 1996. (Pubitemid 26083981)
52. Thomas M, Lloyd-Jones D, Thadhadani R, y col. Hypovitaminosis D in medical inpatients. N Engl J Med 338: 777-83, 1998.
53. Rizzoli R, Eisman JA, Norquist J, y col. Risk factors for vitamin D inadequacy among women with osteoporosis: an international epidemiological study. Int J Clin Pract 60: 1013-9, 2006. Erratum en: Int J Clin Pract 61: 534, 2007.
54. Kuchuk NO, Pluijm SMF, van Schoor NM, y col. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab 94: 1244-50, 2009.
55. Bischoff-Ferrari HA, Kiel DP, Dawson-Hughes B, y col. Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res 24: 935-42, 2009.
56. Sánchez A, Plantalech L. Osteoporosis senil (revisión). Endocrinología (Barc) 44: 141-51, 1997.
57. Plantalech L, Knoblovits P, Cambiazzo E, et al. Hipovitaminosis D en ancianos institucionalizados de Buenos Aires. Medicina (Buenos Aires) 57: 29-35, 1997.
58. Fradinger EE, Zanchetta JR. Vitamin D and bone mineral density in ambulatory women living in Buenos Aires, Argentina. Osteoporos Int 12: 24-7, 2001.
59. Hordon LD, Peacock M. Osteomalacia and osteoporosis in femoral neck fracture. Bone Mineral 11: 247-50, 1990.
60. Bowden SA, Robinson RF, Carr R, Mahan JD. Prevalence of vitamin D deficiency and insufficiency in children with osteopenia or osteoporosis referred to a pediatric metabolic bone clinic. Pediatrics 121: e1585-90, 2008.
61. Kremer R, Campbell PP, Reinhardt T, Gilsanz V. Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J Clin Endocrinol Metab 94: 67-73, 2009.
62. El-Hajj Fuleihan G, Nabulsi M, Tamim H, y col. Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial. J Clin Endocrinol Metab 91: 405-12, 2006.
63. Välimäki VV, Alfthan H, Lehmuskallio E, y col. Vitamin D status as a determinant of peak bone mass in young Finnish men. J Clin Endocrinol Metab 89: 76-80, 2004. (Pubitemid 38183862)
64. Lidor C, Sagiv P, Amdur B, Gepstein R, Otremski I, Hallel T, Edelstein S. Decrease in bone levels of 1,25-dihydroxyvitamin D in women with subcapital fracture of the femur. Calcif Tissue Int 52: 146-8, 1993.
65. Need AG, Horowitz M, Morris HA, Moore R, Nordin C. Seasonal change in osteoid thickness and mineralization lag time in ambulant patients. J Bone Miner Res 22: 757-61, 2007. (Pubitemid 351339105)
66. Rizzoli R, Eisman JA, Norquist J, y col. Risk factors for vitamin D inadequacy among women with osteoporosis: an international epidemiological study. Int J Clin Pract 60: 1013-9, 2006. Erratum en: Int J Clin Pract 61: 534, 2007.
67. Mithal A, Wahl DA, Bonjour JP, y col.; IOF Committee of Scientific Advisors (CSA) Nutrition Working Group. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20: 1807-20, 2009.
68. Holick MF, Siris ES, Binkley N, y col. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90: 3215-24, 2005.
69. Gaugris S, Heaney RP, Boonen S, Kurth H, Bentkover JD, Sen SS. Vitamin D inadequacy among post-menopausal women: a systematic review. QJM 98: 667-76, 2005.
70. Orwoll E, Nielson CM, Marshall LM, y col.; Osteoporotic Fractures in Men (MrOS) Study Group. Vitamin D deficiency in older men. J Clin Endocrinol Metab 94: 1214-22, 2009.
71. Bauer DC, Garnero P, Harrison SL, y col.; Osteoporotic Fractures in Men (MrOS) Research Group. Biochemical markers of bone turnover, hip bone loss, and fracture in older men: the MrOS study. J Bone Miner Res 24: 2032-8, 2009.
72. Ensrud KE, Taylor BC, Paudel ML, y col.; for the Osteoporotic Fractures in Men (MrOS) Study Group. Serum 25-hydroxyvitamin D levels and rate of hip bone loss in older men. J Clin Endocrinol Metab 94: 2773-80, 2009.
73. Cauley JA, Parimi N, Ensrud KE, y col; for the Osteoporotic Fractures in Men (MrOS) Research Group. Serum 25 hydroxyvitamin D and the risk of hip and non-spine fractures in older men. J Bone Miner Res 2009 (en prensa).
74. Simonelli C, Weiss TW, Morancey J, Swanson L, Chen YT. Prevalence of vitamin D inadequacy in a minimal trauma fracture population. Curr Med Res Opin 21: 1069-74, 2005. (Pubitemid 41032697)
75. Holick MF. MrOs is D-ficient. (Editorial). J Clin Endocrinol Metab 94: 1092-3, 2009.
76. MacKenna MJ: Differences in vitamin D status between countries in young adults and the elderly. Am J Med 93: 69-77, 1992.
77. Harris SS, Soteriades E, Dawson-Hughes B. Framinghan Heart Study. Boston Low Income Elderly Osteoporosis Study. J Clin Endocrinol Metab 86: 3801-4, 2001.
78. Plantalech L. Mapa de hipovitaminosis D en Argentina. Actual Osteol 1: 11-5, 2005.
79. Plantalech L, Oliveri B, Bagur A, y col. Factores determinantes de hipovitaminosis D en la ciudad de Buenos Aires. Comité de Investigaciones de la Asociación Argentina de Osteología y Metabolismo Mineral (AAOMM). Comunicación a la 18a Reunión Científica Anual de la AAOMM. Buenos Aires, 2001.
80. Oliveri B, Plantalech L, Bagur A, y co. High prevalence of vitamin D insufficiency in healthy elderly people living at home in Argentina. Eur J Clin Nutr 58: 337-42, 2004.
81. Mansur JL. Oravil Vitamina D3 (Monografía). TRB Pharma, Buenos Aires, 2010. Pp 3-14.
82. Bolland MJ, Bacon CJ, Horne AM, y col. Vitamin D insufficiency and health outcomes over 5 y in older women. Am J Clin Nutr 91: 82-9, 2010.
83. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30:771-7, 2002.
84. Gordon CM, Feldman HA, Sinclair L, y col. Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch Pediatr Adolesc Med 162: 505-12, 2008. (Pubitemid 351786950)
85. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84: 18-28, 2006. (Pubitemid 44699167)
86. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 16: 713-6, 2005.
87. Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 22: 142-6, 2003.
88. Dhesi JK, Jackson SHD, Bearne LM, Moniz C, Hurley MV, Swift CG, y col.Vitamin D supplementation improves neuromuscular function in older people who fall. Age and Ageing 33: 589-95, 2004.
89. Bischoff-Ferrari HA, Borchers M, Gudat F, Dürmüller U, Stähelin HB, Dick W. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 19: 265-9, 2004. (Pubitemid 38116740)
90. Schurman L, Bagur A, Claus-Hermberg H, y col. Guías Argentinas para Diagnóstico, Prevención y Tratamiento de la Osteoporosis 2007. Actual Osteol 3: 117-36, 2007;
91. y Rev Arg Osteol 6(3):27-42, 2007 (doble publicación).
92. Salica D, y col. Consenso Iberoamericano de Osteoporosis SIBOMM 2009. Osteoporosis: Prevención, Diagnóstico y Tratamiento. Disponible en www.sibomm.net
93. Adami S, Giannini S, Bianchi G, y col. Vitamin D status and response to treatment in postmenopausal osteoporosis. Osteoporos Int 20: 239-44, 2009.
94. Antoniucci DM, Vittinghoff E, Palermo L, Black DM, Sellmeyer DE. Vitamin D insufficiency does not affect response of bone mineral density to alendronate. Osteoporos Int 20: 1259-66, 2009.
95. Guardia G, Parikh N, Eskridge T, Phillips E, Divine G, Rao DS. Prevalence of vitamin D depletion among subjects seeking advice on osteoporosis: a five-year cross-sectional study with public health implications. Osteoporos Int 19: 13-9, 2008.
96. Geller JL, Adams JS. Vitamin D therapy. Curr Osteoporos Rep 6: 5-11, 2008.
97. Björkman M, Sorva A, Tilvis R. Responses of parathyroid hormone to vitamin D supplementation: A systematic review of clinical trials. Arch Gerontol Geriatr 48: 160-6, 2009.
98. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, y col. Effect of vitamin D on falls: a metaanalysis. JAMA 291: 1999-2006, 2004.
99. Bikle D, Adams J, Christakos S. Vitamin D: production, metabolism, mechanism of action, and clinical requirements. En: Primer on the metabolic bone diseases and disorders of mineral metabolism, 7th edition (Rosen CD, Compston JE, Lian JB, eds). American Society for Bone and Mineral Research; Washington, 2008. Pp 141-9.
100. Avenell A, Gillespie WJ, Gillespie LD, O'Connell D. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis (Review). Cochrane Database Syst Rev 2: CD000227, 2009.
101. Abrahamsen B, Masud T, Avenell A, y col; DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group. Patient level pooled analysis of 68,500 patients from seven major vitamin D fracture trials in US and Europe. Brit Med J 340: b5463, 2010 (en prensa) DOI: 10.1136/bmj.b5463.
102. Rizzoli R, Bruyère O, Cannata-Andía JB, y col. Management of osteoporosis in the elderly. Curr Med Res Opin 25: 2373-87, 2009.
103. Dawson-Hughes B. Calcium and vitamin D. En: Primer on the metabolic bone diseases and disorders of mineral metabolism, 7th edition (Rosen CD, Compston JE, Lian JB, eds). American Society for Bone and Mineral Research; Washington, 2008. Pp 231-3.
104. Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 68: 854-8, 1998.
105. Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 89: 5387-91, 2004.
106. Houghton LA, Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 84: 694-7, 2006. (Pubitemid 44715649)
107. Holick MF, Biancuzzo RM, Chen TC, y col. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25- hydroxyvitamin D. J Clin Endocrinol Metab 93: 677-81, 2008.
108. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77: 204-10, 2003. Erratum en: Am J Clin Nutr 78: 1047, 2003.
109. Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 85: 6-18, 2007.
110. Hollis BW. Vitamin D requirement during pregnancy and lactation. J Bone Miner Res 22(Suppl 2): V39-44, 2007.
111. Chlebowski RT, Johnson KC, Kooperberg C, y col. Calcium plus vitamin D supplementation and risk of breast cancer. J Natl Cancer Inst 100: 1581-91, 2008.
112. Abbas S, Linseisen J, Slanger T, y col. Serum 25-hydroxyvitamin D and risk of postmenopausal breast cancer - Results of a large case-control study. Carcinogenesis 29: 93-9, 2008. (Pubitemid 351201746)
113. Giovannucci E, Liu Y, Rimm EB, y col. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98: 451-9, 2006.
114. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85: 1586-91, 2007.
115. Jenab M, Bas Bueno-de-Mesquita H, Ferrari P, y col. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. Brit Med J 2010 (en prensa).
116. Crew KD, Shane E, Cremers S, McMahon DJ, Irani D, Hershman DL. High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol 27: 2151-6, 2009.
117. Mann GB, Kang YC, Brand C, Ebeling PR, Miller JA. Secondary causes of low bone mass in patients with breast cancer: a need for greater vigilance. J Clin Oncol 27: 3605-10, 2009.
118. Krishnan AV, Swami S, Peng L, y col. Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology 2010 (en prensa).
119. González-Pardo V, Martin D, Gutkind S, y col. 1- alpha,25-dihydroxyvitamin D3 and its TX527 analog inhibit the growth of endothelial cells transformed by Kaposi sarcoma-associated herpes virus G protein coupled receptor in vitro and in vitro. Endocrinology 2010 (en prensa).
120. Hollis, BW. US recommendations fail to correct vitamin D deficiency. Nat Rev Endocrinol 6: 12-3, 2010.
121. Lee DM, Rutter MK, O'Neill TW, y col. Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur J Endocrinol 161: 947-54, 2009.
122. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79: 820-5, 2004.
123. Isaia G, Giorgino R, Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population (Abstract). Diabetes Care 24: 1496, 2001.
124. Pilz S, März W, Wellnitz B, y col. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 93: 3927-35, 2008.
125. Wehr E, Pilz S, Schweighofer N, y col. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol 161: 575-82, 2009.
126. Kumar J, Muntner P, Kaskel F J, Hailpern SM, Melamed ML. Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics 124: 362-70, 2009.
127. DiMeglio LA. Vitamin D and cardiovascular disease risk in children. Nat Rev Endocrinol 6: 12-3, 2010.
128. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 89-90(1-5): 387-92, 2004.
129. Wehmeier K, Beers A, Haas MJ, y col. Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3. Biochim Biophys Acta 1737: 16-26, 2005. (Pubitemid 41550379)
130. Michos E, Reis J, Shields M, Platz E, Rohrmann S, Rifai N. The association of cardiovascular disease and osteopenia may be mediated through a vitamin D-sex steroid hormone interaction, results from the Third National Health and Nutrition Examination Survey, NHANES-III. Comunicación al Congreso de la American Heart Association; Orlando, 2009.
131. Dogan M, Erol M, Cesur Y, Yuca SA, Doan Z. The effect of 25-hydroxyvitamin D3 on the immune system. J Pediatr Endocrinol Metab 22: 929-35, 2009.
132. Adams JS, Liu PT, Chun R, Modlin RL, Hewison M. Vitamin D in defense of the human immune response. Ann N Y Acad Sci 1117: 94-105, 2007. (Pubitemid 350191275)
133. Bikle DD. Vitamin D and immune function: understanding common pathways. Curr Osteoporos Rep 7: 58-63, 2009.
134. Adams JS, Hewison M. Update in Vitamin D. J Clin Endocrinol Metab 95: 471-8, 2010.